Richard Buxton, who heads up the U.K. Equities group at Old Mutual Global Investors, proposes AstraZeneca executives put their money where their mouths are. In other words, Buxton says AZ should tie executive compensation to results similar to the Pfizer payout.
written on 22.05.2014
Here's an idea for AZ's full-of-promises execs: Tie pay to opportunity cost
